IRIS
FASANO, Serena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 603
NA - Nord America 538
AS - Asia 140
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 536
IE - Irlanda 313
IT - Italia 79
GB - Regno Unito 69
CN - Cina 51
SG - Singapore 45
DE - Germania 28
FR - Francia 26
GR - Grecia 26
SE - Svezia 25
UA - Ucraina 22
KR - Corea 20
TR - Turchia 11
FI - Finlandia 6
IN - India 6
JP - Giappone 3
MY - Malesia 3
BE - Belgio 2
BR - Brasile 2
CL - Cile 2
CZ - Repubblica Ceca 2
PL - Polonia 2
RU - Federazione Russa 2
CA - Canada 1
CO - Colombia 1
EU - Europa 1
GL - Groenlandia 1
HK - Hong Kong 1
PT - Portogallo 1
Totale 1.287
Salva come PNG Salva come JPEG
Città #
Dublin 313
Chandler 96
Santa Clara 92
Jacksonville 69
Princeton 33
Roxbury 32
Medford 24
Singapore 23
Bremen 20
Seoul 20
Caserta 15
Cambridge 11
Des Moines 11
Nanjing 8
Wilmington 8
Beijing 7
Boardman 7
Jinan 7
Ann Arbor 6
Marseille 5
Naples 4
Napoli 4
New York 4
Sant'Angelo in Formis 4
Villa Literno 4
Hyderabad 3
Shenyang 3
Ashburn 2
Brussels 2
Campo Grande 2
Changsha 2
Guangzhou 2
Hebei 2
Jiaxing 2
Kraków 2
Kuala Lumpur 2
Lanzhou 2
Lappeenranta 2
Mcallen 2
Milan 2
Minerbio 2
Mountain View 2
Nanchang 2
Redwood City 2
San Mateo 2
Santiago 2
Taiyuan 2
Taizhou 2
Tianjin 2
Villaricca 2
Zhengzhou 2
Brno 1
Brookline 1
Cagliari 1
Davis 1
Edinburgh 1
Ferrara 1
Genova 1
Gunzenhausen 1
Haikou 1
Harbin 1
Helsinki 1
Hongtong 1
Kiev 1
Kunming 1
Marano Di Napoli 1
Massamá 1
Medellín 1
Moscow 1
Mumbai 1
Munich 1
Nuuk 1
Ottawa 1
Petaling Jaya 1
Prague 1
Woodbridge 1
Xiangfen 1
Totale 907
Salva come PNG Salva come JPEG
Nome #
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 58
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 55
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 55
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 53
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 52
Mortality in Italian patients with rheumatoid arthritis: Evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center 43
Rituximab in the treatment of inflammatory myopathies: a review 41
Lung involvement in stable undifferentiated connective tissue diseases: a rheumatology perspective 41
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 41
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 41
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 40
Current pharmacological treatment of idiopathic inflammatory myopathies 40
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 39
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 39
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 37
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve 37
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. 37
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 36
ILC3 in Axial Spondyloarthritis: the Gut Angle 33
Biologic treatments for idiopathic inflammatory myopathies 33
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 28
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 28
Subclinical Pancreatitis as Onset of Systemic Lupus Erythematosus: Case Report and Review of the Literature 26
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 26
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 25
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 25
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: Results of the DeSScipher inception cohort study 24
Thrombocytopenia in the Antiphospholipid Syndrome 24
Precision medicine in systemic lupus erythematosus 23
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 23
Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review 22
Present and novel biologic drugs in primary Sjogren's syndrome 22
"What is fuelling the immune response in systemic lupus erythematosus?" Evaluating the key metabolites driving plasmablast differentiation 21
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE? 21
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 21
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 20
The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases 16
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study 15
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis 14
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 13
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 12
Systemic lupus erythematosus and the role of the GP 11
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview 10
Recognition and management of systemic lupus erythematosus 10
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 7
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 7
Totale 1.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 0 11 2 25 19 6 4 6 1
2020/2021132 2 0 5 7 37 8 24 2 8 3 35 1
2021/2022193 5 0 0 3 82 0 9 4 10 3 12 65
2022/2023485 39 3 20 14 50 29 0 23 281 1 13 12
2023/2024191 16 17 13 15 80 6 0 1 1 1 5 36
2024/2025136 1 20 4 13 98 0 0 0 0 0 0 0
Totale 1.345